Celladon Corporation
c/o Enterprise Partners Venture Capital
2223 Avenida de la Playa, Suite 300
La Jolla
California
92037
United States
Tel: 858-731-0241
Website: http://www.celladon.net/
Email: info@celladon.net
94 articles about Celladon Corporation
-
Alder CEO Is Stepping Down
3/21/2018
Alder BioPharmaceuticals announced that Randall Schatzman, the company’s president, chief executive officer and director, will be stepping down. -
Eiger Biopharma Closes Merger With Celladon
3/23/2016
-
Former Celladon CEO Named New Leader of Avalanche Biotech
11/20/2015
-
Celladon Reports Second Quarter 2015 Financial Results
8/12/2015
-
Celladon Lays Off More Staff, Considers Liquidation in Wake of Gene Therapy Failure
6/29/2015
-
Celladon Seeks Sale or Partnership and Promotes Paul Cleveland to CEO
6/1/2015
-
SoCal's Celladon Slashes 50% of Workforce to Conserve Capital After Gene Therapy Fails
5/18/2015
-
Celladon Will Lay Off Workers, Loses 80% of Value As Heart Failure Drug Flunks Phase IIb Trial
4/28/2015
-
Celladon Reports Negative Results For CUPID2 Trial Of MYDICAR In Advanced Heart Failure
4/27/2015
-
Celladon Corporation Reports Fourth Quarter And Year-End 2014 Financial Results And Recent Highlights
3/31/2015
-
Celladon Corporation To Report Fourth Quarter And Fiscal 2014 Results On March 31
3/26/2015
-
Novasep And Celladon Corporation Execute MYDICAR API Supply Agreement
3/25/2015
-
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3/16/2015
-
Novasep Selected To Commercially Biomanufacture Celladon Corporation's Mydicar API
2/17/2015
-
Celladon Corporation To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/3/2015
-
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
1/9/2015
-
Celladon Corporation Conducts Initial Scale Up Of Manufacturing Process For MYDICAR To Commercial Scale
1/5/2015
-
Celladon Corporation Added To NASDAQ Biotechnology Index
12/16/2014
-
Celladon Corporation To Present At 11th Global Cardio Vascular Clinical Trial Forum
12/5/2014
-
Celladon Corporation Selected To Present During The "Best Of Circulation Research" Symposium At The American Heart Association Scientific Sessions 2014
11/14/2014